Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
HOME > ACADEMIA
ACADEMIA
- University of Tokyo Admits Patient Information on SIGN Trial Leaked to Novartis
March 17, 2014
- National University Hospitals to Disclose Funding from Autumn, but with Company Names Withheld
March 11, 2014
- JAMS’s Newly Revised COI Management Guidelines Impose Stricter Rules
February 28, 2014
- Japanese Cardiologist Raises Statistical Concerns over CASE-J Study in US Journal
February 28, 2014
- NCNP to Begin Investigator-Initiated Trial of Multiple Sclerosis Treatment
February 28, 2014
- Japan Diabetes Society Crosses Out SMART Study from Its Guidelines
February 25, 2014
- US Journal Officially Announces Retraction of SMART Study
February 24, 2014
- Japan Hypertension Society Halts Support for Maker-Linked Seminars, but Gives Leeway for Luncheons
February 18, 2014
- University of Tokyo Hospital Allegedly Gave Patient Questionnaire Results on SIGN Trial to Novartis without Consent
February 13, 2014
- SMART Study Sub-Analysis Paper to Be Retracted from JSH Journal
February 12, 2014
- University of Tokyo Besieged with Medical, Pharma Research Woes, School’s Credibility at Stake
February 7, 2014
- JAS Sees “No Need” to Change Its Guidelines in Response to 2013 ACC/AHA Guidelines for the Prevention of ASCVD
February 5, 2014
- SGLT-2 Inhibitors “Suited to Patients with Tendency to Obesity”: Prof. Kadowaki of Univ. of Tokyo
February 4, 2014
- Japan Hypertension Society Won’t Co-Sponsor or Support Drug Maker-Linked Seminars for Now
January 29, 2014
- JCS’s 2013 Guidelines for Treatment of AF Recommend Dabigatran and Apixaban in Moderate-Risk Patients
January 29, 2014
- SMART Study Should Be Removed from CKD Guidelines: Society Panel Chair
January 22, 2014
- SMART Study Retracted from US Journal, Chief Investigator to Resign as Hospital Director
January 22, 2014
- AJMC Announces Guidelines for COI Management at Research and Medical Institutions
December 25, 2013
- Chiba University Finds No Proof of Manipulation in Diovan Study
December 18, 2013
- Nagoya University Denies Diovan Clinical Data Manipulated
December 16, 2013
ページ
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…